Soru

Zorluk: ZorReproductive Endocrinology and Infertility

An evaluation is requested for a 15-year-old adolescent who has not yet experienced menarche or any breast development. She is significantly shorter than her peers, with her height charting at the 2nd percentile for age. Examination demonstrates a broad chest with widely spaced nipples and a low posterior hairline. Pelvic examination reveals normal prepubertal female external genitalia. Arrange the following diagnostic and management steps in the most appropriate chronological order for this patient.

  1. 1Measurement of serum follicle-stimulating hormone (FSH) concentration
  2. 2Peripheral blood karyotype analysis
  3. 3Transthoracic echocardiography
  4. 4Initiation of unopposed low-dose transdermal estrogen
  5. 5Addition of cyclic progestin therapy

Cevap

The correct sequence is: Measurement of serum FSH -> Karyotype analysis -> Transthoracic echocardiography -> Initiation of estrogen -> Addition of cyclic progestin.
The correct sequence logically follows the diagnostic and therapeutic principles for primary amenorrhea with absent breast development. Initial evaluation requires FSH testing to localize the defect to the ovaries. The clinical stigmata strongly suggest Turner syndrome, prompting karyotype analysis for definitive diagnosis. Once confirmed, screening for critical congenital anomalies with echocardiography is the standard of care before focusing on long-term endocrine management. Puberty induction relies on mimicking normal physiology: starting with low-dose estrogen to promote initial breast budding and bone growth, and intentionally delaying the addition of progestin for 1-2 years to prevent abnormal tubular breast formation while eventually securing endometrial protection.

Adım Adım Çözüm

1
Determine the first laboratory evaluation based on the physical examination.
Measurement of serum FSH concentration is selected.
The patient has delayed puberty (absent breast development), pointing toward a defect in estrogen production. FSH differentiates central from peripheral causes.
2
Select the appropriate follow-up test for hypergonadotropic hypogonadism in a patient with dysmorphic features.
Peripheral blood karyotype analysis is ordered.
The clinical phenotype strongly suggests Turner syndrome, which must be confirmed genetically to guide further management.
3
Identify necessary baseline screening upon confirmation of the diagnosis.
Transthoracic echocardiography is performed.
Patients with Turner syndrome have a high risk of congenital heart defects that require immediate identification before focusing on endocrinologic therapy.
4
Establish the initial pharmacological step for puberty induction.
Unopposed low-dose transdermal estrogen is initiated.
Estrogen is required to promote initial breast budding, uterine growth, and bone mineral accretion.
5
Determine the timing for endometrial protection.
Cyclic progestin therapy is added.
Progestins are intentionally delayed for 1-2 years to optimize breast contour and avoid abnormal tubular breast development, after which they are necessary to prevent endometrial hyperplasia.

Anahtar Kavram

Diagnostic algorithm and sequential management of primary amenorrhea secondary to Turner syndrome.
Bu soruyu puanla